Metabolix, Inc. to Present at Investor Conference
CAMBRIDGE, Mass., Mar 12, 2008 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on developing clean, sustainable solutions for the world's needs for plastics, chemicals and energy, today announced that it will be presenting at the CitiGroup Small and Mid-Cap Conference taking place March 17 - 19, 2008 in Las Vegas.
Dr. Jay Kouba, the Company's Chairman of the Board, will be presenting on Tuesday, March 18, 2008 at 9:25 a.m. Pacific Time (12:25 p.m. Eastern Time). Dr. Kouba will be accompanied at the conference by Rick Eno, the recently appointed CEO of Metabolix. The webcast can be accessed on the company's website at www.metabolix.com in the Investor Relations section under the Webcasts & Presentations tab.
For those unable to listen to the presentation live, the webcast will be archived and can be accessed from the Company's website.
About Metabolix
Founded in 1992, Metabolix, Inc. is an innovation driven bioscience company focused on providing sustainable solutions for the world's needs for plastics, chemicals and energy. The Company is taking a systems approach, from gene to end product, integrating sophisticated biotechnology with advanced industrial practice. Metabolix is now developing and commercializing Mirel(TM) bioplastics, a sustainable and biodegradable alternative to petroleum based plastics. Mirel is suitable for injection molding, cast and blown film, sheet, extrusion coating, and thermoforming. Metabolix is also developing a proprietary platform technology for co-producing plastics, chemicals and energy from crops such as switchgrass, oilseeds and sugarcane. For more information, please visit www.metabolix.com. (MBLX-G)
SOURCE: Metabolix, Inc.
Metabolix, Inc. 617-583-1700 www.metabolix.com or Investor Relations: ICR Kathleen Heaney, 203-803-3585 ir@metabolix.com
Copyright Business Wire 2008
News Provided by COMTEX
